The C-suite view of where AI is being used and what’s on the horizon

MATTER, with the support of EVERSANA INTOUCH, is producing AI in Commercial Pharma, a four-part series exploring key AI opportunities pharma brand teams face today.

The series will kick off with a fireside chat featuring Chad LaCrosse, vice president of global commercial business technology solutions at AbbVie, in conversation with Steven Collens, CEO of MATTER. Drawing on his experience at AbbVie, Chad will share learnings and perspectives on how AI is evolving across commercial pharma. The conversation will explore emerging opportunities, practical considerations and lessons from early AI initiatives.

Agenda:

3:00pm CT | Doors open

3:30pm CT | Panel discussion begins

4:30pm CT | Networking reception

5:00pm CT | Event concludes

Part of the AI in Commercial Pharma event series
Explore all four events and choose the one that’s right for you.

About Chad LaCrosse

Chad LaCrosse is vice president of global commercial business technology solutions at AbbVie, a global research-based biopharmaceutical company whose mission is to discover and deliver innovative medicines that make a remarkable impact on people’s lives.

In his current role, Chad drives value by defining strategic information technology initiatives that enable AbbVie’s Commercial goals. He is responsible for strategically allocating resources to maximize efficiency, effectiveness and business results, while managing risk to ensure safe, secure, and sustainable growth. Passionate about the possibilities of technology, Chad excels in bringing innovation to life by optimizing cross-functional team performance and empowering employees to achieve their full potential.

Chad is a dynamic leader known for creating high-performing teams, establishing successful strategies, delivering critical programs and driving innovation across the pharma value chain. He started his career as an SAP practitioner for a Big 5 consulting company and moved from consulting to IT in 2001. He earned his degree in chemical engineering from the University of Wisconsin. Outside of work, Chad enjoys sports, golf and spending time with his wife and two children.

About MATTER

At MATTER, we believe collaboration is the best way to improve healthcare. The MATTER collaborative includes more than 1,000 current and alumni startups from around the world, working together with hospitals, health systems, universities and industry-leading companies to build the future of healthcare. Together we are accelerating innovation, advancing care and improving lives.

About EVERSANA INTOUCH

EVERSANA INTOUCH helps life sciences organizations accelerate commercial success by unifying strategy, creative, execution, data with AI and human expertise to deliver measurable business impact at enterprise scale.